Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids

IMPORTANCE: Buprenorphine is an effective and cost-effective medication to treat opioid use disorder (OUD), but is not readily available to many people with OUD in the US. The current cost-effectiveness literature does not consider interventions that concurrently increase buprenorphine initiation, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Claypool, Anneke L., DiGennaro, Catherine, Russell, W. Alton, Yildirim, Melike F., Zhang, Alan F., Reid, Zuri, Stringfellow, Erin J., Bearnot, Benjamin, Schackman, Bruce R., Humphreys, Keith, Jalali, Mohammad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199347/
https://www.ncbi.nlm.nih.gov/pubmed/37204803
http://dx.doi.org/10.1001/jamahealthforum.2023.1080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199347/
https://www.ncbi.nlm.nih.gov/pubmed/37204803
http://dx.doi.org/10.1001/jamahealthforum.2023.1080

Ejemplares similares